-
EP3681526
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3681526
| EP3681526 - PEPTIDE INHIBITORS OF INSULIN-DEGRADING ENZYME [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 05.08.2022 Database last updated on 20.07.2024 | |
| Former | Request for examination was made Status updated on 19.06.2020 | ||
| Former | The international publication has been made Status updated on 22.03.2019 | Most recent event Tooltip | 05.08.2022 | Application deemed to be withdrawn | published on 07.09.2022 [2022/36] | Applicant(s) | For all designated states The Regents of the University of California 1111 Franklin Street 12th Floor Oakland, CA 94607-5200 / US | [2020/30] | Inventor(s) | 01 /
LEISSRING, Malcolm A. 1061 South Coast Highway Laguna Beach, California 92651 / US | [2020/30] | Representative(s) | Mewburn Ellis LLP Aurora Building Counterslip Bristol BS1 6BX / GB | [2020/30] | Application number, filing date | 18857213.5 | 11.09.2018 | [2020/30] | WO2018US50508 | Priority number, date | US201762557662P | 12.09.2017 Original published format: US 201762557662 P | [2020/30] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019055431 | Date: | 21.03.2019 | Language: | EN | [2019/12] | Type: | A1 Application with search report | No.: | EP3681526 | Date: | 22.07.2020 | Language: | EN | The application published by WIPO in one of the EPO official languages on 21.03.2019 takes the place of the publication of the European patent application. | [2020/30] | Search report(s) | International search report - published on: | US | 21.03.2019 | (Supplementary) European search report - dispatched on: | EP | 06.09.2021 | Classification | IPC: | C07K7/08, C07K7/06, A61K38/08, A61K38/05 | [2021/27] | CPC: |
C07K7/08 (EP,US);
C07K7/64 (US);
A61K38/08 (US);
A61K38/10 (US);
A61K38/12 (US);
A61K38/55 (US);
A61K45/06 (US);
A61K8/64 (EP,US);
A61P17/02 (EP,US);
A61P3/10 (US);
A61Q19/00 (EP);
A61Q19/08 (US);
C07K14/81 (US);
C07K7/06 (EP,US);
C12N9/6489 (EP);
C12Y304/24056 (EP);
A61K2800/91 (EP);
A61K2800/92 (EP);
A61K38/00 (EP,US)
(-)
|
| Former IPC [2020/30] | A61K38/08, A61K38/05, C07K7/06 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/30] | Title | German: | PEPTID-INHIBITOREN DES INSULINABBAUENDEN ENZYMS | [2020/30] | English: | PEPTIDE INHIBITORS OF INSULIN-DEGRADING ENZYME | [2020/30] | French: | INHIBITEURS PEPTIDIQUES DE L'ENZYME DE DÉGRADATION DE L'INSULINE | [2020/30] | Entry into regional phase | 20.03.2020 | National basic fee paid | 20.03.2020 | Search fee paid | 20.03.2020 | Designation fee(s) paid | 20.03.2020 | Examination fee paid | Examination procedure | 20.03.2020 | Examination requested [2020/30] | 30.10.2020 | Amendment by applicant (claims and/or description) | 01.04.2022 | Application deemed to be withdrawn, date of legal effect [2022/36] | 04.05.2022 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2022/36] | Fees paid | Renewal fee | 28.09.2020 | Renewal fee patent year 03 | Penalty fee | Additional fee for renewal fee | 30.09.2021 | 04 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A] - MAIANTI J P ET AL, "Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones", NATURE, (20140521), vol. 511, no. 7507, doi:10.1038/nature13297, pages 94 - 98, XP055565653 [A] 1-15 * the whole document, in particular abstract; figure 1b;; compound 6bK * DOI: http://dx.doi.org/10.1038/nature13297 | [A] - LEISSRING M A ET AL, "Designed Inhibitors of Insulin-Degrading Enzyme Regulate the Catabolism and Activity of Insulin", PLOS ONE, vol. 5, no. 5, doi:10.1371/journal.pone.0010504, (20100501), page e10504, URL: https://storage.googleapis.com/plos-corpus-prod/10.1371/journal.pone.0010504/1/pone.0010504.pdf?X-Goog-Algorithm=GOOG4-RSA-SHA256&X-Goog-Credential=wombat-sa@plos-prod.iam.gserviceaccount.com/20210525/auto/storage/goog4_request&X-Goog-Date=20210525T094124Z&X-Goog-Expires=86400&X-Goog-SignedHeaders=h, XP055807011 [A] 1-15 * the whole document, in particular abstract; figures 1, 2 * DOI: http://dx.doi.org/10.1371/journal.pone.0010504 | [XP] - SUIRE C N ET AL, "Peptidic inhibitors of insulin-degrading enzyme with potential for dermatological applications discovered via phage display", PLOS ONE, (20180215), vol. 13, no. 2, doi:10.1371/journal.pone.0193101, page e0193101, XP055475376 [XP] 1-15 * the whole document * DOI: http://dx.doi.org/10.1371/journal.pone.0193101 | [T] - LEISSRING M A ET AL, "International Journal of Molecular Sciences Targeting Insulin-Degrading Enzyme in Insulin Clearance", INT. J. MOL. SCI, vol. 22, (20210101), page 2235, URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956289/pdf/ijms-22-02235.pdf, XP055807025 [T] 1-15 * the whole document * DOI: http://dx.doi.org/10.3390/ijms22052235 | International search | [A]US2002168711 (ROSEN CRAIG A [US], et al) [A] 1, 2, 3/1-2 * ; SEQ ID NO: 838 *; | [A]US2004158891 (THOMPSON JOHN E [CA], et al) [A] 1, 2, 3/1-2* ; paragraph [0015]; SEQ ID NO: 19 *; | [A]US2012028894 (FRENKEL DAN [IL], et al) [A] 1, 2, 3/1-2 * ; abstract; paragraphs [0012], [0018]-[0020], [0064], [0070] *; | [A]WO2016172631 (HARVARD COLLEGE [US]) [A] 1, 2, 3/1-2 * ; abstract; paragraphs [0006], [0008], [0039]; SEQ ID NO: 4 * |